Cell Bio Human TechLtd Balance Sheet Health
Financial Health criteria checks 5/6
Cell Bio Human TechLtd has a total shareholder equity of ₩44.9B and total debt of ₩6.1B, which brings its debt-to-equity ratio to 13.6%. Its total assets and total liabilities are ₩52.9B and ₩7.9B respectively. Cell Bio Human TechLtd's EBIT is ₩3.3B making its interest coverage ratio -40.6. It has cash and short-term investments of ₩16.2B.
Key information
13.6%
Debt to equity ratio
₩6.09b
Debt
Interest coverage ratio | -40.6x |
Cash | ₩16.21b |
Equity | ₩44.92b |
Total liabilities | ₩7.94b |
Total assets | ₩52.86b |
Financial Position Analysis
Short Term Liabilities: A318160's short term assets (₩27.0B) exceed its short term liabilities (₩7.9B).
Long Term Liabilities: A318160's short term assets (₩27.0B) exceed its long term liabilities (₩68.4M).
Debt to Equity History and Analysis
Debt Level: A318160 has more cash than its total debt.
Reducing Debt: A318160's debt to equity ratio has increased from 0.5% to 13.6% over the past 5 years.
Debt Coverage: A318160's debt is well covered by operating cash flow (92.9%).
Interest Coverage: A318160 earns more interest than it pays, so coverage of interest payments is not a concern.